Translocation and mutant ROS kinase in human non-small cell lung carcinoma

Details for Australian Patent Application No. 2008314567 (hide)

Owner Cell Signaling Technology, Inc.

Inventors Gu, Ting-Lei; Guo, Ailan

Agent Spruson & Ferguson

Pub. Number AU-A-2008314567

PCT Pub. Number WO2009/051846

Priority 60/999,668 18.10.07 US

Filing date 20 October 2008

Wipo publication date 23 April 2009

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/051846 Priority application(s): WO2009/051846

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008314569-Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof

2008314565-Synthetic analogues of neural regeneration peptides